{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:30:08Z","timestamp":1792729808810,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Left atrial appendage (LAA) closure has been well evaluated in the prevention of stroke in patients with atrial fibrillation. Device embolization remains one of the most common complications. To the best of our knowledge, there have been no reports of late discovery of LAA occluder device embolization at 1.5\u2009years after implantation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We describe the case of a 77-year-old man who underwent uneventful LAA closure. Echocardiography performed the next day showed the device in place. The patient was discharged but was then lost to follow-up. 1.5\u2009years later, he was admitted for ischemic stroke. Transesophageal echocardiography showed the absence of the occluder device in the LAA. Computed tomography scan of the abdomen showed the device in the abdominal aorta. Due to the high cardiovascular risk, the device was kept in place and the patient was treated medically.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Per-procedural and late device embolization are not uncommon. Review of the literature however showed no report of late discovery of device embolization at 1.5\u2009years. Follow-up echocardiography is mandatory for the detection of endothelialization or embolization.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01589-9","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T11:03:02Z","timestamp":1592823782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Late discovery of left atrial appendage occluder device embolization: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Mohamad Jihad","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"B\u00e9nic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-7194","authenticated-orcid":false,"given":"Jacques","family":"Mansourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"issue":"5","key":"1589_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ahj.2006.02.005","volume":"151","author":"RB Fountain","year":"2006","unstructured":"Fountain RB, Holmes DR, Chandrasekaran K, Packer D, Asirvatham S, Van Tassel R, et al. The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial. Am Heart J. 2006 May;151(5):956\u201361.","journal-title":"Am Heart J"},{"issue":"1","key":"1589_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes","year":"2014","unstructured":"Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"9689","key":"1589_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet Lond Engl. 2009;374(9689):534\u201342.","journal-title":"Lancet Lond Engl"},{"issue":"13","key":"1589_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.jacc.2007.02.035","volume":"49","author":"PB Sick","year":"2007","unstructured":"Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007 Apr 3;49(13):1490\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1589_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.002212","volume":"1","author":"MJ Swaans","year":"2012","unstructured":"Swaans MJ, Post MC, Rensing BJWM, Boersma LVA. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012 Oct;1(5):e002212.","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"1589_CR6","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","volume":"61","author":"VY Reddy","year":"2013","unstructured":"Reddy VY, M\u00f6bius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013 Jun 25;61(25):2551\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1589_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1253\/circj.CJ-13-0828","volume":"78","author":"Y Matsuo","year":"2014","unstructured":"Matsuo Y, Sandri M, Mangner N, Majunke N, D\u00e4hnert I, Schuler G, et al. Interventional closure of the left atrial appendage for stroke prevention. Circ J. 2014;78(3):619\u201324.","journal-title":"Circ J"},{"issue":"9","key":"1589_CR8","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.jcin.2014.01.177","volume":"7","author":"AJ P\u00e9rez Matos","year":"2014","unstructured":"P\u00e9rez Matos AJ, Swaans MJ, Rensing BJWM, Heijmen RH, Mast EG, Boersma LVA, et al. Embolization of a left atrial appendage closure device unmasked by intermittent left bundle branch block. JACC Cardiovasc Interv. 2014;7(9):e115\u20137.","journal-title":"JACC Cardiovasc Interv."},{"key":"1589_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12872-019-1170-8","volume":"19","author":"M Chopra","year":"2019","unstructured":"Chopra M, Wong YH, Sondergaard L, De Backer O. Percutaneous retrieval of an embolized left atrial appendage closure device from the left atrium in a patient with previous MitraClip. BMC Cardiovasc Disord. 2019;19:196. https:\/\/doi.org\/10.1186\/s12872-019-1170-8.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"1589_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jacc.2016.10.010","volume":"69","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Gibson DN, Kar S, O\u2019Neill W, Doshi SK, Horton RP, et al. Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2017 Jan 24;69(3):253\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"31","key":"1589_CR11","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","volume":"37","author":"LVA Boersma","year":"2016","unstructured":"Boersma LVA, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016 Aug;37(31):2465\u201374.","journal-title":"Eur Heart J"},{"issue":"19","key":"1589_CR12","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","volume":"312","author":"VY Reddy","year":"2014","unstructured":"Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014 Nov 19;312(19):1988\u201398.","journal-title":"JAMA."},{"issue":"7","key":"1589_CR13","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.hrthm.2015.03.020","volume":"12","author":"J Pillarisetti","year":"2015","unstructured":"Pillarisetti J, Reddy YM, Gunda S, Swarup V, Lee R, Rasekh A, et al. Endocardial (watchman) vs epicardial (lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015 Jul;12(7):1501\u20137.","journal-title":"Heart Rhythm"},{"issue":"3","key":"1589_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ccd.26782","volume":"89","author":"TR Betts","year":"2017","unstructured":"Betts TR, Leo M, Panikker S, Kanagaratnam P, Koa-Wing M, Davies DW, et al. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: a multicenter registry. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2017;89(3):484\u201392.","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"issue":"4","key":"1589_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/jce.13168","volume":"28","author":"J Saw","year":"2017","unstructured":"Saw J, Fahmy P, Azzalini L, Marquis J-F, Hibbert B, Morillo C, et al. Early Canadian multicenter experience with WATCHMAN for percutaneous left atrial appendage closure. J Cardiovasc Electrophysiol. 2017 Apr;28(4):396\u2013401.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1589_CR16","doi-asserted-by":"crossref","unstructured":"Fanari Z, Goel S, Goldstein JA. Successful percutaneous retrieval of embolized transcatheter left atrial appendage closure device (watchman) using a modified vascular retrieval forceps. Cardiovasc Revasc Med. 2017;18(8):616-18.","DOI":"10.1016\/j.carrev.2017.05.019"},{"issue":"7","key":"1589_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/jce.13201","volume":"28","author":"J Gabriels","year":"2017","unstructured":"Gabriels J, Beldner S, Khan M, Zeitlin J, Jadonath R, Patel A. Embolization of watchman device following a hybrid radiofrequency ablation of atrial fibrillation and watchman implantation procedure. J Cardiovasc Electrophysiol. 2017 Jul;28(7):835\u20136.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"1589_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.carrev.2016.01.006","volume":"17","author":"C Fastner","year":"2016","unstructured":"Fastner C, Lehmann R, Behnes M, Sartorius B, Borggrefe M, Akin I. Veno-venous double lasso pull-and-push technique for transseptal retrieval of an embolized watchman occluder. Cardiovasc Revascularization Med Mol Interv. 2016;17(3):206\u20138.","journal-title":"Cardiovasc Revascularization Med Mol Interv"},{"issue":"10","key":"1589_CR19","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.jcin.2016.02.020","volume":"9","author":"H Deng","year":"2016","unstructured":"Deng H, Liao H, Liu Y, Chen S, Xue Y, Zhan X, et al. Acute heart failure caused by dislocation of a WATCHMAN left atrial appendage Occluder. JACC Cardiovasc Interv. 2016 May 23;9(10):e97\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"1589_CR20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1540-8167.2007.00784.x","volume":"18","author":"C St\u00f6llberger","year":"2007","unstructured":"St\u00f6llberger C, Schneider B, Finsterer J. Serious complications from dislocation of a watchman left atrial appendage occluder. J Cardiovasc Electrophysiol. 2007 Aug;18(8):880\u20131.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"1589_CR21","first-page":"yty001","volume":"2","author":"C Barth","year":"2018","unstructured":"Barth C, Behnes M, Borgrefe M, Akin I. Peri-interventional embolization of left atrial appendage occlusion devices: two manoeuvers of successful retrieval. Eur Heart J Case Rep. 2018;2(1):yty001.","journal-title":"Eur Heart J Case Rep"},{"issue":"12","key":"1589_CR22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/clc.22478","volume":"38","author":"LI B\u00f6sche","year":"2015","unstructured":"B\u00f6sche LI, Afshari F, Sch\u00f6ne D, Ewers A, M\u00fcgge A, Gotzmann M. Initial experience with novel Oral anticoagulants during the first 45 days after left atrial appendage closure with the watchman device. Clin Cardiol. 2015 Dec;38(12):720\u20134.","journal-title":"Clin Cardiol"},{"issue":"47","key":"1589_CR23","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1093\/eurheartj\/ehu361","volume":"35","author":"S Obeid","year":"2014","unstructured":"Obeid S, Nietlispach F, Luscher TF, Alibegovic J. Percutaneous retrieval of an endothelialized AMPLATZER cardiac plug from the abdominal aorta 6 months after embolization. Eur Heart J. 2014;35(47):3387.","journal-title":"Eur Heart J"},{"issue":"1","key":"1589_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ccd.25891","volume":"86","author":"A Aminian","year":"2015","unstructured":"Aminian A, Lalmand J, Tzikas A, Budts W, Benit E, Kefer J. Embolization of left atrial appendage closure devices: a systematic review of cases reported with the watchman device and the amplatzer cardiac plug. Catheter Cardiovasc Interv. 2015;86(1):128\u201335.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"suppl_1","key":"1589_CR25","doi-asserted-by":"publisher","first-page":"i97","DOI":"10.1093\/europace\/euy015.283","volume":"20","author":"C Benic","year":"2018","unstructured":"Benic C, Noel A, Fofana A, Pouliquen MC, Didier R, Fatemi M, Mansourati J. P474 Late discovery of a left atrial appendage occluder embolization. EP Europace. 2018;20(suppl_1):i97. https:\/\/doi.org\/10.1093\/europace\/euy015.283.","journal-title":"EP Europace"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01589-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:30:36Z","timestamp":1624318236000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01589-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01589-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"27 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient\u2019s next-of-kin gave written consent for their relatives personal or clinical details along with any identifying images to be published in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Professor Jacques Mansourati is consultant and receives research fees from Boston Scientific and Abbott Laboratories. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}